Evidence map›Paper›PMID 31916393›Full record

ArticleOrthopaedic surgery2020

Influence of MicroRNA-141 on Inhibition of the Proliferation of Bone Marrow Mesenchymal Stem Cells in Steroid-Induced Osteonecrosis via SOX11.

Chen-Yang Meng, Fei Xue, Zhen-Qun Zhao, Ting Hao, Shi-Bing Guo, Wei Feng

Open access · goldAbstract read
In one paragraph

Article in Orthopaedic surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chen-Yang MengOrthopedics Department, Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Fei XueOrthopedics Department, Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Zhen-Qun ZhaoOrthopedics Department, Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Ting HaoOrthopedics Department, Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Shi-Bing GuoOrthopedics Department, Inner Mongolia Institute of Orthopedics, Hohhot, China.
Wei FengOrthopedics Department, Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.ORCID https://orcid.org/0000-0001-7913-2011
Second Affiliated Hospital of Inner Mongolia Medical University · CNInner Mongolia Electric Power Survey & Design Institute (China) · CN

Funding

Natural Science Foundation of Inner Mongolia 201703122
6 · The paper itself

Abstract

objectiveTo investigate whether miR-141 and the sex determination region of Y chromosome box 11 (SOX11) play roles in steroid-induced avascular necrosis of the femoral head (SANFH), and to explore whether miR-141 could target SOX11 to influence the proliferation of bone marrow mesenchymal stem cells (BMSC).

methodsBone marrow mesenchymal stem cells (BMSC) were isolated and cultured from 4-week-old Sprague Dawley rats. A flow cytometry assay was performed to identify BMSC. BMSC were divided into two groups: a control group and a dexamethasone (DEX) group. BMSC were transfected by miR-141 mimic, miR-141 inhibitor, and SOX11. Real-time polymerase chain reaction (PCR) assay was performed to investigate the mRNA expression of miR-141 and SOX11. The results were used to determine the effect of transfection and to verify the expression in each group and the association between miR-141 and SOX11. Luciferase reporter assay revealed the targeted binding site between miR-141 and the 3'-untranslated region of SOX11 mRNA. MTT assays were performed to investigate the proliferation of BMSC in the miR-141 mimic, miR-141 inhibitor, and SOX11 groups.

resultThe results of the flow cytometry assay suggested that cells were positive for CD29 and CD90 while negative for CD45. This meant that the isolated and cultured cells were not hematopoietic stem cells. In addition, cell transfection was successful based on the expression of miR-141 and SOX11. According to the results of real-time PCR assay, the mRNA expression of miR-141 in SANFH was upregulated (4.117 ± 0.042 vs 1 ± 0.027, P < 0.001), while SOX11 was downregulated (0.611 ± 0.055 vs 1 ± 0.027, P < 0.001) compared with the control group. Based on the results of the luciferase experiment, MiR-141 could directly target the expression of SOX11. Inhibition of miR-141 could upregulate the expression of SOX11 (2.623 ± 0.220 vs 1 ± 0.095, P < 0.001) according to the results of a real-time PCR assay. MiR-141 inhibited the proliferation of BMSC (0.618 ± 0.092 vs 1.004 ± 0.082, P < 0.001), while suppression of miR-141 increased the proliferation of BMSC (0.960 ± 0.095 vs 0.742 ± 0.091, P < 0.001). Furthermore, according to the results of the MTT assay, SOX11 promoted the proliferation of BMSC (1.064 ± 0.093 vs 0.747 ± 0.090, P < 0.001).

conclusionMiR-141 inhibited the proliferation of BMSC in SANFH by targeting SOX11. Inhibition of miR-141 upregulated the expression of SOX11 and promoted the proliferation of BMSC. MiR-141 and SOX11 could be new targets for investigating the mechanism of SANFH.

Indexed as

AnimalsBone Marrow CellsCell ProliferationDexamethasoneFemur Head NecrosisFlow CytometryMesenchymal Stem CellsMicroRNAsRatsRats, Sprague-DawleySex-Determining Region Y ProteinSOXC Transcription FactorsDexamethasoneMicroRNAsMirn141 microRNA, ratSex-Determining Region Y ProteinSox11 protein, ratSOXC Transcription FactorsBone marrow mesenchymal stem cellsGlucocorticoidMicroRNA-141SOX11Steroid induced avascular necrosis of femoral head

Identifiers

PMID31916393
PMCPMC7031553
OpenAlexW2999425408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.